Free Webinar on Alzheimer’s Disease with Dr. Tramontano of The NeuroCognitive & Behavioral Institute
Functional Brain Mapping and Neuromodulation: In the Treatment of Alzheimer’s Disease
Thu, Mar 28, 2019 1:00 PM – 2:00 PM EDT
Brain mapping using electrical neuroimaging allows us to see the neurophysiological inside the brains of patients with Alzheimer’s Disease. Neuromodulation uses non-invasive techniques such as tDCS, tRNS and tACS to modulate these regions and cortical network abnormalities in order to resuscitate these regions and to enhance the cortex’s compensatory capacity.
Missed the live webinar?
Watch the recording at your convenience. Feel free to reach out to us if you have any questions.
Presenter: Gerald Tramontano, Ph.D., Medical Director
About Dr. Tramontano:
Dr. Gerald Tramontano conducts a variety of sponsored and investigator-initiated pharmacological, nutraceutical and neurodiagnostic research. As a Principal Investigator, Dr. Tramontano has completed approximately 70 clinical research studies. His clinical research experience in drug development ranges from bioavailabilty / bioequivalent studies, as well as, first in humans Phase I studies through Phase IV clinical trials. The majority of his clinical research has been investigating functional brain mapping, neuromodulation, behavioral, biological and pharmacological treatments for patients with a variety of cognitive and neuropsychiatric conditions, in particular – neurodegenerative diseases such as Alzheimer’s disease. He has authored several published neuroscience-related and pharmacology articles in medical and forensic journals. Read more about Dr. Tramontano.
